Sign in

CIK 0001840706

  • Accelerated filer
  • Emerging growth company

SOPHiA GENETICS SA

Sign in to watch
Ticker
SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 216941060
Business address
LA PIECE, CH-1180, ROLLE, Switzerland, 00000
  1. 4 Planned sale Chief Medical Officer sold 5,000 shares at $5.66 ($28,306)
  2. 4 Planned sale Executive Chairman sold 44,381 shares at an average $6.45 ($286,099)
  3. 4 Planned sale Chief Medical Officer sold 5,000 shares at $5.70 ($28,505)
  4. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $5.70 ($22,819)
  5. 4 Planned sale Executive Chairman sold 8,500 shares at $5.62 ($47,791)
  6. 4 Planned sale Executive Chairman sold 17,685 shares at $5.28 ($93,327)
  7. 4 Planned sale Chief Financial Officer sold 1,592 shares at $5.29 ($8,419)
  8. 4 Planned sale Chief People Officer sold 4,241 shares at $5.05 ($21,430)
  9. 4 Planned sale Chief Technology Officer sold 5,285 shares at $5.10 ($26,957)
  10. 4 Planned sale Chief Scientific Officer sold 7,393 shares at $5.17 ($38,242)
  11. 4 Planned sale Chief Executive Officer sold 9,838 shares at $5.22 ($51,354)
  12. 4 Open-market sale Chief Sales Officer sold 216 shares at an average $5.03 ($1,087)
  13. 4 Planned sale Chief Medical Officer sold 7,393 shares at $5.16 ($38,156)
  14. 4 Planned sale Executive Chairman sold 22,486 shares at $5.26 ($118,164)
  15. 4 Planned sale Executive Chairman sold 83,679 shares at an average $6.06 ($506,690)
  16. 4 Planned sale Chief Executive Officer sold 51,442 shares at an average $5.80 ($298,155)
  17. 4 Planned sale Chief Technology Officer sold 6,944 shares at $5.51 ($38,229)
  18. 4 Planned sale Chief Medical Officer sold 5,000 shares at $5.50 ($27,525)
  19. 4 Planned sale Chief Financial Officer sold 774 shares at $5.38 ($4,164)
  20. 4 Planned sale President sold 422 shares at $5.38 ($2,270)

Page 3 of 8 · 156 filings